original ) (raw )[18F]FLT-PET Imaging Does Not Always "Light Up" Proliferating Tumor Cells
Dana Buckman
Clinical Cancer Research, 2011
View PDFchevron_right
Increase of [18F]FLT Tumor Uptake In Vivo Mediated by FdUrd: Toward Improving Cell Proliferation Positron Emission Tomography
Angelika Delaloye , Yves Dupertuis , Simon Ametamey
Molecular Imaging and Biology, 2011
View PDFchevron_right
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation
James Mountz
Nuclear Medicine Communications, 2009
View PDFchevron_right
Reproducibility of the kinetic analysis of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography in mouse tumor models
Sang-we Kim
Nuclear Medicine and Biology, 2009
View PDFchevron_right
[18F]FLT PET for Non-Invasive Monitoring of Early Response to Gene Therapy in Experimental Gliomas
Wolf-dieter Heis
Molecular Imaging and Biology, 2011
View PDFchevron_right
In vivo validation of 3'deoxy-3'-[(18) F] fluorothymidine ([(18) F] FLT) as a proliferation imaging tracer in humans: correlation of [(18) F] FLT uptake by positron emission …
Mark Muzi
… cancer research: an …, 2002
View PDFchevron_right
[18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment
Dmitry Soloviev
European Journal of Cancer, 2012
View PDFchevron_right
[18F]FLT PET for Non-Invasive Assessment of Tumor Sensitivity to Chemotherapy: Studies with Experimental Chemotherapy TP202377 in Human Cancer Xenografts in Mice
Kamille Erichsen
PLoS ONE, 2012
View PDFchevron_right
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors
Mark Muzi
Clinical cancer research : an official journal of the American Association for Cancer Research, 2002
View PDFchevron_right
Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
Olivier CASELLES
Clinical Cancer Research, 2010
View PDFchevron_right
Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls
Andreas Buck
PET clinics, 2014
View PDFchevron_right
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Ben Slotman
Molecular Imaging and Biology, 2007
View PDFchevron_right
Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model
Otto Boerman
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014
View PDFchevron_right
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography
David Collingridge
Cancer research, 2003
View PDFchevron_right
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT
Andrei Volgin
European journal of nuclear medicine and molecular imaging, 2008
View PDFchevron_right
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for Monitoring the Response of Tumors to Radiotherapy in Mice
Hideo Tsukada
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography 1
Clyde Hutchinson
2003
View PDFchevron_right
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
Gabriela kramer-MareK
The Journal of Nuclear Medicine, 2018
View PDFchevron_right
Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors
Erlinda Gordon
Nuclear Medicine and Biology, 1999
View PDFchevron_right
A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [18F]fluorothymidine-positron emission tomography
Sang-we Kim
Investigational New Drugs, 2013
View PDFchevron_right
FLT-PET Imaging of Radiation Responses in Murine Tumors
William Mcbride
Molecular Imaging and Biology, 2008
View PDFchevron_right
Potential Applications of PET Imaging in Developing Novel Cancer Therapies
Abass Alavi
Journal of Vascular and Interventional Radiology, 2000
View PDFchevron_right
PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model
Joseph Backer
European Journal of Nuclear Medicine and Molecular Imaging, 2012
View PDFchevron_right
Comparison of semiquantitative fluorescence imaging and PET tracer uptake in mesothelioma models as a monitoring system for growth and therapeutic effects
Yasushi Arano
Nuclear Medicine and Biology, 2008
View PDFchevron_right
Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft
Yoshimasa Kitagawa
EJNMMI Research, 2016
View PDFchevron_right
Evaluation of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-l-arabinofuranosyluracil ([18F]-l-FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-d-FMAU and [18F]FLT
Juri Gelovani
European Journal of Nuclear Medicine and Molecular Imaging, 2008
View PDFchevron_right
Reproducibility study of [18F]FPP(RGD)2 uptake in murine models of human tumor xenografts
Gayatri Gowrishankar , Edwin Chang
European Journal of Nuclear Medicine and Molecular Imaging, 2011
View PDFchevron_right
Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice
Hideo Tsukada
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004
View PDFchevron_right
Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3'-Deoxy-3'-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
Valerie Longo
Journal of Nuclear Medicine, 2008
View PDFchevron_right
In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study
Rachid Benhida
Biochemistry and Biophysics Reports
View PDFchevron_right